<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Research on hMLH1 and hMSH2 mutations tend to focus on <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (LS) and LS-like <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>No studies to date have assessed the role of hMLH1 and hMSH2 genes in mass <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (without preselection by MSI or early <z:hpo ids='HP_0011007'>age of onset</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to identify novel hMLH1 and hMSH2 DNA variants, to determine the mutation frequencies and sites in both <z:hpo ids='HP_0003745'>sporadic</z:hpo> and LS <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and their relationships with clinicopathological characteristics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in Northeast of China </plain></SENT>
<SENT sid="3" pm="."><plain>452 <z:hpo ids='HP_0003745'>sporadic</z:hpo> and 21 LS <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients were screened for germline and <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in hMLH1 and hMSH2 genes with PCR-SSCP sequencing </plain></SENT>
<SENT sid="4" pm="."><plain>We identified 11 hMLH1 and seven hMSH2 DNA variants in our study cohort </plain></SENT>
<SENT sid="5" pm="."><plain>Six of them were novel: four in hMLH1 gene (IVS8-16 A&gt;T, c.644 GAT&gt;<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTT</z:e>, c.1529 CAG&gt;CGG and c.1831 ATT&gt;TTT) and two in hMSH2 gene (-39 C&gt;T, insertion AACAACA at c.1127 and deletion AAG at c.1129) </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, germline and <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> frequencies of hMLH1/hMSH2 gene were 15.59% and 17.54%, respectively (p = 0.52) </plain></SENT>
<SENT sid="7" pm="."><plain>Germline mutations present in hMLH1 and hMSH2 genes were 5.28% and 10.78%, respectively (p&lt;0.01) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001428'>Somatic mutations</z:hpo> in hMLH1 and hMSH2 genes were 6.73% and 11.70%, respectively (p = 0.02) </plain></SENT>
<SENT sid="9" pm="."><plain>In LS <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, both germline and <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> frequencies of hMLH1/hMSH2 gene were 28.57% </plain></SENT>
<SENT sid="10" pm="."><plain>The most prevalent germline mutation site in hMSH2 gene was c.1168 CTT&gt;TTT (3.90%), a polymorphism </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0001428'>Somatic mutation</z:hpo> frequency of hMLH1/hMSH2 gene was significantly different in proximal, distal colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (p = 0.03) </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings elucidate the mutation spectrum and frequency of hMLH1 and hMSH2 genes in <z:hpo ids='HP_0003745'>sporadic</z:hpo> and LS <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and their relationships with clinicopathological characteristics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>